Evexia Lifecare Limited

BSE: EVEXIA · Trading - Chemicals · sector

₹1.73BSE close 2026-10-26

Key numbers

Market cap₹325 cr

Price₹1.73

52w high / low₹2 / ₹0

P/E–Sector median 20.4x

P/B0.8xSector median 0.8x

Book value₹2.3

Dividend yield–Sector median 0.57%

ROE0.4%Sector median 5.6%

ROCE0.5%Sector median 8.7%

OPM1.7%Sector median 2.0%

Debt / equity0.01xSector median 0.15x

EV/EBITDA162.6xSector median 12.1x

Interest cover170.0x

Current ratio1.50x

Sales growth 3y+17.1%Sector median +17.1%

Profit growth 3y-7.2%Sector median -7.2%

PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 13 companies in Trading - Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹2 cr vs borrowings ₹3 cr (FY26): borrowings are higher by ₹0 cr.
Operating profit covered interest 170.0x in the last 12 months.
Other income was 52% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹1.73 on 2026-10-26: -24.1% from the 52-week high, +268.1% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹4.23 · low ₹0.51

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	24	22	26	25	37	31
EBITDA	1	1	0	0	1	1
OPM %	5.5%	4.9%	0.4%	1.0%	3.0%	1.7%
Other income	0	0	0	0	0	0
Net profit	0	1	0	0	1	0
EPS (₹)	0.00	0.03	0.00	0.00	0.00	0.00
Revenue YoY					+55.8%	+39.8%
Profit YoY					+141.9%	-34.9%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	72	69	55	110	110	119
EBITDA	2	2	2	4	3	2
Net profit	1	2	1	1	2	2
EPS (₹)	0.20	0.03	0.02	0.01	0.00	–
Revenue growth		-4.0%	-20.1%	+101.2%	-0.2%	–
Profit growth		+148.7%	-42.2%	-19.1%	+71.0%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+17.1%	–	–
Net profit	-7.2%	–	–
EPS	–	–	–
Share price	–	-30.4% (2y)	-6.4%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	459	435
Borrowings	386	3
Cash & equivalents	6	2
Total assets	920	872
Fixed assets	22	18
Capital work in progress	0	0
Investments	716	711
Receivables	93	85
Inventory	3	3
Payables	64	56

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	0	-23
Cash from investing	-29	53
Cash from financing	32	-28
Capex	7	3
Free cash flow	-7	-27

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	0.2%	0.4%
ROCE %	0.3%	0.5%
Debtor days	307	281
Inventory days	11	9
Payable days	261	197
Cash conversion cycle (days)	57	93
Working capital days	129	104

Peers in Trading - Chemicals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
UNIENTER	₹604 cr	29.9x	0.2x	0.8%	0.8%	-15.6%	+179.1%	0.57%
VINYLINDIA	₹440 cr	23.6x	3.4x	14.5%	19.2%	2.0%	-13.6%	2.92%
VERITAS	₹389 cr	12.5x	0.1x	-0.0%	0.8%	2.0%	+139.0%	0.03%
EVEXIA	₹325 cr	–	0.8x	0.4%	0.5%	1.7%	+17.1%	–
BHAVIK	₹303 cr	22.4x	2.1x	9.3%	12.9%	2.7%	–	–
SRD	₹247 cr	13.4x	2.0x	15.9%	17.4%	5.4%	–	0.13%
A1L	₹225 cr	20.4x	4.2x	16.5%	14.3%	3.6%	+1.2%	0.76%
SHIVTEXCHEM	₹154 cr	2.0x	0.4x	22.3%	36.6%	4.9%	–	–
YASHCHEM	₹51 cr	21.2x	1.2x	5.6%	8.7%	0.2%	+38.3%	–
AUREATE	₹45 cr	8.6x	5.0x	57.7%	108.9%	6.0%	–	–

All 13 companies in Trading - Chemicals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Commodities
Industry	Trading - Chemicals
Sub-industry	Trading - Chemicals
Symbol	EVEXIA
BSE code	524444
ISIN	INE313M01030
Face value	₹1.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.